TrialThe British journal of ophthalmology2023

Utilisation of composite endpoint outcome to assess efficacy of tocilizumab for non-infectious uveitis in the STOP-Uveitis Study.

Muhammad Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.